A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating multiple sclerosis.

Advancements in MS include promising therapies like BTK inhibitors and myelin repair, evolving biomarkers, and a focus on cognition, signaling a promising future in precision medicine.

New research shows early Multiple Sclerosis brain damage is dynamic and reversible. Myelin swellings can shrink and disappear ...

Some research suggests that people with multiple sclerosis are at a higher risk of atherosclerosis. An increased risk hasn’t been established, and we don’t know how MS might increase the risk. Having ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why. Researchers found that inflammation in the brain disrupts the energy supply of ...

Cognitive health is not only the absence of cognitive impairment. It's the ability to maintain mental efficiency, flexibility, and emotional balance despite the burden of the disease. Cognitive ...

Pediatric-onset MS (POMS) is more inflammatory than adult-onset MS, with frequent relapses and cognitive issues, affecting 7.6% of MS cases. The 2017 McDonald criteria improved POMS diagnostic ...

Both Guillain-Barré syndrome and multiple sclerosis involve an autoimmune attack on the nervous system. Guillain-Barré syndrome affects the peripheral nervous system, while multiple sclerosis impacts ...

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or untreated. A machine learning model may help by analyzing routinely collected ...

Obexelimab met the primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo over weeks ...